Polypharmacy Risk Reduction in the Context of Complexity, Frail and End of Life
Polypharmacy Risk Reduction in the Context of Complexity, Frail and …
Polypharmacy Risk Reduction in the Context of Complexity, Frail and End of Life See Resource »
Medication Reduction
Case Studies in Complex Drug Reviews – Polypharmacy
(Dr. Ted Rosenberg, 2015)
Use of Statins in Residential Care
(Dr. Chris Rauscher, 2017)